CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatment of squamous non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal and gastro-esophageal junction cancers, and diffuse large B-cell lymphoma; BMS-986249, a CTLA-4 Probody therapeutic drug, which is in Phase I/II clinical trials for the treatment of metastatic melanoma; and BMS-986288, an anti-CTLA-4 Probody drug, which is in Phase I clinical trials for the treatment of solid tumors. It also develops CX-2043, a conditionally activated ADC targeting the epithelial cell adhesion molecule, as well as CX-904, a conditionally activated epidermal growth factor receptor for the treatment of solid tumor. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc. to develop Probody therapeutics. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of CytomX Therapeutics Inc..
CytomX Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of CytomX Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of CytomX Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of CytomX Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of CytomX Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of CytomX Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 CytomX Therapeutics Inc.- Key Facts
2.2 CytomX Therapeutics Inc.- Geographic Locations
2.3 CytomX Therapeutics Inc.- Subsidiaries and Affiliates
2.4 CytomX Therapeutics Inc.- Business Divisions
2.5 CytomX Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. CytomX Therapeutics Inc. Strategic Analysis Review
3.1 CytomX Therapeutics Inc.- Key Strategies
3.2 CytomX Therapeutics Inc.- Company Outlook Statement
3.3 CytomX Therapeutics Inc.- SWOT Analysis
3.3.1 CytomX Therapeutics Inc.- Key Strengths
3.3.2 CytomX Therapeutics Inc.- Key Weaknesses
3.3.3 CytomX Therapeutics Inc.- Potential Opportunities
3.3.4 CytomX Therapeutics Inc.- Potential Threats
3.4 CytomX Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 CytomX Therapeutics Inc.- Business Overview
4.2 CytomX Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 CytomX Therapeutics Inc.- Key Products
5.2 CytomX Therapeutics Inc.- Key Service Areas
5.3 CytomX Therapeutics Inc.- Key Brands
6 Company Developments
6.1 CytomX Therapeutics Inc.- Company History
6.2 CytomX Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 CytomX Therapeutics Inc.- Income Statements
7.2 CytomX Therapeutics Inc.- Balance Sheet
7.3 CytomX Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 CytomX Therapeutics Inc.- Direct Competitors
8.2 CytomX Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 CytomX Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 CytomX Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!